You will now be redirected to the GD3 website
Integrated Analytical Solutions, Inc. is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3SERVICES
IAS is your go-to source for drug metabolism testing
Specializing in GLP and non-GLP bioanalytical services using LC-MS/MS and immunoassay methods. Our team works with you to determine the right bioanalytical approach for each stage of development and every size of budget. We’re dedicated to developing methods for our client’s most challenging drug candidates and biomarkers.From off-the-shelf assays to compound-specific investigations, IAS is here to support your high-throughput screening (HTS) and lead optimization efforts for drug metabolism testing.
- IAS has economical solutions for providing metabolic stability data for all of your early discovery screens. The data we provide will facilitate prioritization of your discovery compounds.
- Our scientific staff is trained to provide expert guidance for metabolite identification and drug-drug interaction studies. The findings from these studies are critical to the selection of appropriate species for in vivo toxicology studies and for developing clinical testing strategies.
- We’re always on-call to perform the analytics for your in-house metabolism experiments.
